Andrew McClary
Known title: DirectorCIK: 0001972173
Associated companies
Transaction History
| AZTR | ▼ Sell | Other | 42,347 | — | 6/21/2023 | View on chart |
| AZTR | ▼ Sell | Other | 16,975 | — | 6/21/2023 | View on chart |
| AZTR | ▼ Sell | Other | 42,347 | — | 6/21/2023 | View on chart |
| AZTR | ▼ Sell | Other | 16,975 | — | 6/21/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Azitra Announces $3.5M Common Stock Sale Agreement and Updated Valuation
Azitra Inc. entered a sales agreement with A.G.P. to offer up to $3.5 million of common stock. The company also updated its valuation to reflect progress in its cosmetic and EGFRi rash programs. These developments were noted in a Benzinga report that listed Azitra among 12 healthcare stocks moving in Thursday’s after‑market session.
Azitra Announces $3.5M Common Stock Sale Agreement and Updated Valuation. Azitra Inc. entered a sales agreement with A.G.P. to offer up to $3.5 million of common stock. The company also updated its valuation to reflect progress in its cosmetic and EGFRi rash programs. These developments were noted in a Benzinga report that listed Azitra among 12 healthcare stocks moving in Thursday’s after‑market session.